-transparent.png){kind=logo}
Methimazole (1-methyl-2-mercaptoimidazole; MMI) increases thyroglobulin mRNA and thyroid peroxidase mRNA concentration in human thyroid cells and in FRTL-5 cells. MMI (1-10,000 microM) gives a dose-dependent increase of thyroglobulin concentration in the medium of human thyroid cells and FRTL-5 cells. The stimulation by MMI has no effect on the TSH-induced cAMP production and occurs in the presence or absence of thyrotropin (TSH). TSH increases the thyroglobulin and thyroid peroxidase mRNA synthesis in human thyroid cells and FRTL-5 cells. The accumulation of thyroglobulin in the medium has an optimum at 100 microU TSH/ml in FRTL-5 cells. This optimum can also be found in most human thyroid cell cultures.
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
June 1991,
Endocrinology,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
January 2006,
Acta histochemica,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
November 1997,
Biochemical and biophysical research communications,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
January 1992,
Thyroid : official journal of the American Thyroid Association,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
July 1997,
Biochemical and biophysical research communications,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
November 1999,
Molecular and cellular endocrinology,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
March 1989,
Molecular endocrinology (Baltimore, Md.),
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
January 1994,
Peptides,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
January 1989,
Nihon Naibunpi Gakkai zasshi,
L M Leer, and
M Cammenga, and
E R van der Vorm, and
J J de Vijlder
November 1991,
Acta endocrinologica,
